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Abstract. Interrelation of blood lipid spectrum, level of systemic inflammation and mass of body in patients with 
coronary heart disease in combination with nonalcoholic fatty liver disease and their dynamics in terms of 
secondary prevention. Kuryata O.V., Grechanyk M.M. The article analyzes the blood lipid spectrum, level of 
systemic inflammation and their dynamics depending on body mass index in patients with coronary heart disease 
(CHD) in combination with nonalcoholic fatty liver disease (NAFLD) under the of influence statin therapy. 20 men 
(mean age 56,4±1,44 years) with CHD and NAFLD were examined. Levels of triglycerides (TG), total cholesterol (TC), 
low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), C-reactive protein (CRP) 
were studied. 2 groups of patients according to BMI were distinguished: group 1 consisted of 9 (45%) patients who are 
overweight (BMI 25 to 30 kg/m2), group 2-8 (40%) with first degree of obesity (BMI 30 to 35). It was at found that at 
the initial state BMI increase at the range of 25-35 kg/m2 was not associated with a significant difference in the lipid 
spectrum, on the other hand on the background of treatment with pitavastatin in the dose of 2 mg for 8 weeks in patients 
with BMI of 25-30 kg/m2 more intensive reduction of TG (56.6%), LDL-C (31,8%), total cholesterol (22%), CRP 
(29.8%) and increased HDL-C (14,7%) was registered in contrast to the patients with BMI 30-35 kg/m2 – 33,7%, 
22,8%, 8,8%, 10,1%, 11,9% respectively. Thus, in patients with CHD and NAFLD, pitavastatin in the dose of 2 mg has 
a moderate lipid-lowering effect, causes no significant increase in liver transaminases, which required dose adjustment 
or discontinuation of the drug. 
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??????????? ??????? ?????? (???) ? ??????-
??? ??????????? ???????? ???? ?? ??????????
???? ? ????????? ????????????, ?????????????
? ?????????? ??? ????????-?????????? ????-
???????? (???). ?? ?????? ????????? ??????-
????? ??????????????? (???), ? 2030 ???? ?????
23,3 ???????? ??????? ????? ?? ??? ????-
???????, ?? ??? 9,4 ???????? (16,5%) ???????
????? ???? ??????????? ?????????? ????-
????????? ????????, ???? ?????? 51% ???????
?????? ? ?????????? ????????? ? 45% - ? ??????-
???? ???.
??????? ???????? ???? ? ??????? ???????????
??????????????? ??????? ? ????????? ? ??? [5]. 
????????????? ??????? ??????? ??????
(?????) ? ????????? ????? ???????????????
??? ???????? ?????? ????????? ?????? [7] ?,
???????? ??????????? ??????????????, ????????
??????????????? ???????? ????????????????
??????????? ?????????????????? ???????. ????-
??????? ?????, ??? ??? ???????? ??????? ???-
????? ?????? ????????? ? ?????. ? ?????-
??????? W. Dunn ??????????? ?????????? ??
980 ?????????? ? ????? ?? ?????????? 8 ???,
??????????? ?????? ????????? 6594 ????????,
???? ????????, ??? ? ????????? ? ????? ????-
?????? ????? ??????? ????????-??????????
??????????, ???????? ? ???????? 45–54 ??? [14].
???????????? ???????? ? ????????? ?????
??????? ???????? ?????, ????? ??????? ??????
???????? ????? ????????????, ??????? ????-
???? ? 20–80% ????????? ? ????? [13]. ???-
????????? ????????? ??????? ? ?????? ??????
????????? ???????? ????????? ?????? ??????-
??????? (??), ?????????? ?????? ???????????
????????????? ??????? ????????? (?? ????).
???? ???????? ??????????? ??? ????? ?????-
?????? ????????????? ?? ???? ?????????? ???.
?????????????, ???????? ? ??? ? ?????????
? ????? ????????? ? ??????? ?????????.
?????? ?? ?????? ??????? ?????????? ???????-
????? ?????? ??. ?? ?????? ????????????, ???-
??????? ??????? ?? ???????? ?????? ?? ? ??-
??????? ????? ????????? ????????????, ? ??
?????????? ???? - ????????????, ?????? ????-
??? ?????????? ???????????? ? ????????? ?
???????????????????? ? ????????? ? ??????????
?????? ?? ???????????. ?? ??? ??? ???????-
??????? ???????? ?????? ????? ????????????-
????? ?????? ?????? ?????????? ? ????????? ?
?????. ????????, ??? ???????? ?????? ?????-
??? ???????? ???????? ???????? ?????????
?????????? ???????????, ?????? ?????? ????-
????? ??????? ??????????? ?????? ?? ????
?????? ?????? ?????? ????????????? ?????-
????? ?? ??? ??? ?? ???????. ????? ???????,
???????? ????????? ???????????? ? ?????????
? ??? ? ????? ?????????? ??? ????? ??-
????????.
? ????????? ????? ???????? ??????? ?????
????????? ???-???-????????? ?????????? ????-
????? ???????????? (??????© ????? Recordati, 
??????), ???????, ? ??????? ?? ?????? ????-
?????????? ??????? ?????? ??????????, ????
????????????? ???????????????? ? ???????????
?? ??????? ????????? P450 (CYP) 2C9, ? ?? ????
CYP3A4, ? ???????? ?????????? ??????????, ???
?????? ????????? ??? ?????????? ? ????????? ?
????? [1]. 
??? ??????? ?????? ???????????? ? ??????
??????????? ?????????????? ????????????
LIVES - ???????????? ???????????? ? ????????-
????? ?????????????, ? ???????? 20 279 ??-
??????? ? ????????????????????, ??????? ???-
?????? ???????????? ? ???? 1??, 2?? ? 4??
????????????? ?? 2 ???, ??????? ??????? ??
???? ??? ????????? ? 88,2% ????????? ? ???-
??? ????????-?????????? ?????? (???)
(<160 ??/??), ? 82,7% ????????? ?? ??????? ???
(<140 ??/??), ? 66,5% ????????? ? ??????? ???
(<120 ??/??). ??? ???? ???? ? ????????? ?
?????? ??????? ?? ???? ?? 104 ?????? ?????-
????? ?????????? ???????? ?????? ???????????
(???) ?? 21,0%, ?? ???? ?? 31,3% ? ?? ??
6,1%, ? ??????? ???? ????????? ?? 24% [6]. 
? ?? ????? ??? ? ??????????? ESC ???????
?????????? ??????? ???????? ?? ????, ?
????? ????????????? ???????????? ????????
??????????? ? ???????????? ?????????? ??????
(AC?/???, 2013) ?? ?????????????????? ????-
??? ????? ???????? ???????????. ? ?????-
??????? ??????????? ???????? ?????? ??????
?????????, ??????????? ? ??????????????????
???????, ? ????? ????????????? ???????, ???-
?????? ??? ?????? ???? ????????. ???????
????????, ??? ???????????? ??????? ? ?????-
??????? (2013) ???????????? ?? ??????? ?????-
??????? [11]. 
????? ?????? ???????????? ???? ???????
??????????? ??????????? ????????? ???????,
?????? ?????????? ??????????, ????? ???? ? ??-
??????? ? ??? ? ????????? ? ????? ? ??
???????? ??? ???????? ??????????????.
????????? ??????? ????????????
??????????? 20 ?????? ? ??? ? ????????? ?
????? ? ???????? ?? 46 ?? 73 ??? (???????
??????? – 56,4±1,44 ????). ??????? ??? ???
????????? ? ???????????? ? ???????? ??? ??-
????? ? 436 ?? 03.07.2006 ? "? ???????????
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?????????? ???????? ??????????? ?????? ??
????????????? "???????????". ??????? ?????-
?????? ?????????? II ? III ??????????????
????? – ???????? ????????????? ????????? ????-
?????? ??????????? (?? ?? NYHA) [8]. ?
??????????? ?????? ?????????? ??????????? ??-
???????? ?? ?? ???? ???????????????? ? 15 
(75%), ??? – ? 5 (25%) ?????????, ?????? ???????
???????? ? ???????? – ? 4 (20%), ?????? ????-
????? ????????? ?????????????? ?? ?????-
??????? ???? ? ???????? – ? 5 (25%). ??????
(45%) ??????? ???? ????????????.
??????? «?????» ? ???-10 (???, 1998) 
???????????. ? ????????? ???????????? ?????-
????? ??????????? ????? ??????? ????????,
??????????? ?????????? ?????, ?????????????
?????? ?????, ?????????????? ???????????? ??-
???? [8]. ?? ??????????? ??????????? ?????????
?????????? ????????? ?????? ??? ?? 2 ???? ?
5 ??????? (25%.), ??? ?? 2 ???? - ? 2 (10%), 
??? - ? 5 (25%), ?????????? ?????? - ? 4 (20%), 
?????????? ??????? - ? 8 (40%) ?????????.
?????????? ????????? ? ???????????? ???-
???? ?????????? ???????? ????????, ???????
???, ??????? ?????, ??????? ????????????.
???????? ??????????: ?????????????? ??????-
?????; ??????? ???????? ? ???????? ?????? ?? 6 
???????; ?????? ????????? ????????? ???????-
??????? ? ???????? ?????? ?? 6 ???????;
??????? ???????; ???????? ????????? ?????
??????; ???????? ??????; ??????????? ????-
?????? ?????? ? ?????? ?????????????; ??????
? ??????????? ??????????? ?????; ?????? ???-
?????? ???????????????; ???????? 4 ???????;
????? ????? ???????? ?? 4 ?????? ?? ??-
??????????.
???? ????????? ?????????????? ???????-
????? ??????, ????????? ??????? ????????
?????????, ????????????? ???????.
?????? ????????????: ????????? ?????????-
??? ????????? ????????? ? ??????????, ???
???????? ???? ????????? ?? 2 ?????? ? ??-
????????? ?? ??????? ????? ????: 1 ?????? - 9 
(45%) ??????? ? ?????????? ?????? ???? (???
?? 25 ?? 30 ??/?2), 2 ?????? - 8 (40%) ? ?????-
???? 1 ??????? (??? ?? 30 ?? 35 ??/?2). ???
???????? ????????? ???????? ???????????? ?
??????? ???? 2 ?? ? ?????. ????????? ????????
?????? ?? ?????? ????????????? ? ????????????
??????? ???? ??????? 8 ?????? ??????????
(???????? ????????????? ???????????? ??-
?????? ?????????????), ????????????? ?????? – 
10 - 12 ???? ?? ?????? ??????? ? ?????????????
?????? ?????????? ???????????, ???????, ????-
?????? ? ???????? ? ????????? ?????.
?????? ????? ???? ???????????? ?? ????-
??????? ??????? [15]. ?????????? ?????????? ?
????????? ????? ??, ???, ?? ???? ???????
??? ? ?????????????? ????????? ????? «Hu-
man» (????????) ?? ????????????? ???????????
«Chemistry Analyzer RT-1904C».  
??????? ?? ???? ??????? ?? ??????? W.T. 
Friedewald [2]: 
?? ???? = ??? – (?? ???? + ??/2,2).
???????????? ?? ? ??????? ??-???? ????-
?????? ?? ???????:
?? ??-???? = ??? - ?? ????.
????????????? ??????????? ??/???? ???
?????? ????? ???????? ????????-?????????? ??-
???????.
????????? ??????? ????? ????????? ??
?????????? ???????? ??????????? ??????????,
??????? ?????????? ?? ??????? Cockroft-Gault 
???????? ???????????? ???????????? ??-
??????? ????? [3], ??????? ?-??????????? ?????
(???) ??????? ???????????? ????? ??????-
????????????? ??????????? ? ????????? ? ??-
????? ??????? «HUMATEX» («Human», ???-
?????) ?? ?????????????????? ???????????
«Chemistry Analyzer RT-1904C».   
?????????????? ????????? ?????? ?????-
???? ? ?????????????? ??????? ????????
«STATISTICA® for Windows 6.0» (StatSoft Inc.), 
«Microsoft® Excel 2010» (Microsoft®). ???
??????? ?????? ????????? ?????? ?????????-
???????? ??????????. ?????? ???????????? ?
???? ??????? (??) ??? ???????? ???????????-
??? ?????????, ???????????? - ? ?????????. ???
????????? ??????????? ???? ????????? ?????
???????????? ???????? ?????????? (Wilcoxon 
test), ??? ?????? ??????????? ????? ??????????
???????????? ?????????????? ?????? ? ????????
???????????? ???????? ?????????? ????????
(r) [4]. 
?????????? ? ?? ??????????
??? ???????? ????????? ???????????? ?
???????????? ? ??????????.
??? ??????? ??????????? ???? ?????? (n=20) ?
????????? ? ??? ? ????????? ? ????? ?? ????
??????? ?????????????? ? ???? 2 ?? ???????
??? ????? 8 ?????? ??????? ?????????? ???-
????? ? 6,08±0,19 ?? 4,95±0,21 ?????/? (??
18,4%) (?=0,00008) (???. 1); ??????? ?? ???? – 
? 4,17±0,22 ?? 3,11±0,20 ?????/? (?? 25,4%) 
(?=0,0001) (???. 2); ??????? ???????????? ?? – ?
2,40±0,22 ?? 1,49±0,19 ?????/? (?? 37,9%, 
?<0,05) (?=0,00008) (???. 3); ??????? ?? ?????
– ? 0,91±0,08 ?? 0,59±0,08 ?????/? (?? 35,1%) 
(?=0,002); ??????????? ????????????? – ?
???????? ????????
??????? ???????????106
4,71±0,27 ?? 3,24±0,24 ?????/? (?? 24,1%) 
(?=0,0001). ? 9 (45%) ????????? ??????? ???????
???????? ?????? ??? ????? 4,5 ?????/?, ? 8 
(40%) ?? ???? - ????? 2,6 ?????/?, ? 13 (65%) 
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???. 1. ???????? ????????? ?????? ???
?????????? ?????????? ? ????? ?? ????
???????? ?????? ???????????? ???????? ?????-
???????? ????????? ??????? ?, ??????????????,
???. ??????? ?? ???? ? ???? ?????? (n=20) 
????????? ? 1,06±0,04 ?? 1,17±0,04 ?????/? (??
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???. 2. ???????? ????????? ?????? ?? ????
















? ? ? ? ? ? ? ? ? ? : ??? 1 - ? ?????? ???????, ??? 2 - ????? 8 ?????? ???????; * - ????????????? ????? ???????????? ?? ????????
??????????.
???. 3. ???????? ????????? ?????? ????????????? (??) ?? ???? ???????
???????? ?? ???? ???????? ?????????
??/?? ????. ?? ???????????? ??????, ? ???-
????? ???? ????????? ???????????? ? ????????
374 ????????? ???????? ?????, ??????? ?????-
?????? ?????????????? ? ??????????????? ?????.
?????????, ??? ????????????? ?????????????-
??????? ????????? ?????????? ??????? ?????-
????? ????????????? ? ?????????? ??/????
[12]. ?????? ??????? ??????????: 2 ???.??. – ???-
??, 2 - 4 ???.??. - ??????? ???, 4 ???.?? ? ????? - 
????? ??????? ???. ? ?????? ????????????
??????????? ??/?? ???? ? ???? ?????? (n=20) 
?? 8 ?????? ??????? ????????? ? 2,41±0,30 ??
1,35±0,26 ?????/? (?? 43,9%) (?=0,00001) (???.5), 
??? ???? 19 (95%) ????????? ???????? ??????-
???? ????? 2 ???.??., ??? ????????????? ?????, ?
?? ????? ??? ? ?????? ?????????? ? 11 (55%) 
????????? ?????????? ??? ???? 2 ???.??. (??-
















? ? ? ? ? ? ? ? ? ? : ????????????? ????? ???????????? ?? ???????? ?????????? ?<0,05. 



















? ? ? ? ? ? ? ? ? ? : ????????????? ????? ???????????? ?? ???????? ?????????? ?<0,05 
???. 5. ???????? ????????? ?????? ??/????
?? ??-???? ????? ??????????????? ???
????? ??????? ????????? ???, ??? ?? ????, ?
??????????? ? ????????? ? ?????????????????-
????? ? ????????? ? ?????????????? ??????-
???, ????????????? ??????? ???????? ?? ??-
???? <4 ?????/?. ? ?????? ???????????? ????-
?????? ??????????? ???????? ?? ??-????
(n=20) c 5,03±0,19 ?? 3,99±0,20 ?????/? (??
20,6%) (?=0,00008). 
? ???????????? ? ???????? ???????????? 1 
?????? ????????? 9 (45%) ??????? (???
27,47±0,45), 2 ?????? – 8 (40%) – ???????? ?
????????? 1 ??????? (??? 32,0±0,38). ?? ??-
?????? ???????????????, ?????????????? ?
???????, ??????????? ?????? ?? ?????? ????-
?????????????? ??????? ?????????????? ? ????
2 ?? ??????????? ?? ?????????? ????? ?????
(??? ???? ?????????? p>0,05). ???????? ?? ??-
????????????? ? ??????????? ????????? ? ???-
????????? ????????? ??????? ????? ? ??????
?????????? ??????????.
??????? ???????? ??????????? ????????? ??????? ?? ? ????? ???????
?? ??????? ? ??????????? ?? ??????? ????? ???? (M±m) 
?????????? ?????? 1 ??? n-9 
?????? 2 
???????? 1?? n-8 ?
?? ??????? 6,54±0,28 5,51±0,31 0,0928 ???
?????/? ????? 8 ?????? 5,01±0,26  * 5,02±0,41  * 0,779 
?? ??????? 2,10±0,29 2,52±0,46 0,4838 ??
?????/? ????? 8 ?????? 0,91±0,16  * 1,67±0,38  * 0,068 
?? ??????? 1,10±0,065 0,97±0,049 0,06 ?? ????
?????/? ????? 8 ?????? 1,29±0,057  * 1,08±0,053  * 0,025 
?? ??????? 4,62±0,34 3,85±0,32 0,06 ?? ????
?????/?
????? 8 ?????? 3,15±0,24  * 2,97±0,39  * 0,57 
?? ??????? 0,82±0,097 0,88±0,198 1,0 ?? ?????
?????/?
????? 8 ?????? 0,34±0,093  * 0,68±0,14  * 0,17 
?? ??????? 1,64±0,86 2,56±1,86 0,16 ??/????
?????/? ????? 8 ?????? 0,68±0,125  * 1,54±0,58* 0,011 
?? ??????? 5,44±0,80 4,59±0,88 0,16 ?? ?? ????
?????/? ????? 8 ?????? 3,65±0,24  * 3,87±0,40  * 0,888 
??????????: ??? - ????? ??????????, ?? - ????????????, ?? ???? - ?????????? ????????????? ??????? ?????????, ?? ???? - ??????????
????????????? ?????? ?????????,?? ????? - ?????????? ????????????? ????? ?????? ?????????, ??/???? - ?? ??????????? ????????????? ?
????????????? ??????? ?????????, ?? ??-???? - ?????????? ??????????????? ??????? ?????????, ? - ????????????? ????? ???????????? 1-? ?
2-? ?????? ?? ???????? ?????????? (?<0,05), * - ????????????? ????? ???????????? ? ?????? ? ? ????? ???????????? (?<0,05). 
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? ?????? 1 ?? ?????? ??????? ???????? ???-
??? ?????????????? ????? ??? ? ?????
r=0,54, (p=0,007). ? ?????? 2 ??? ????????????
? ??? r=0,43, (p=0,01), ?? r=0,67, (p=0,01), 
???? r=0,542, (p=0,01), ????? r=0,44, 
(p=0,01), ??/???? r=0,41, (p=0,01), ??-????
r=0,70, (p=0,01).  
? ?????? 1 ? ? ?????? 2 ??????????? ?????-
?????? ???????? ???, ???, ?? ????, ??








??? ?? ???? ?? ?? ?????
??? ?????? n=20* ?????? 1 n=9* ?????? 2 n=8*
*- ????????????? ????? ???????????? ?? ???????? ?????????? (?<0,05). 
???. 6. ??????? ????????? ??????????? ???, ?? ????, ??, ?? ????? ?? ???????
????????, ??? ?????? ????? ???? ????????
?????? ??????????????? ???????? ?????????
????????? ??? ???????????? ??? [15]. ?? ??????
??????? ? ????????? ? ????????? 1 ??????? ??-
?????????????? ????? ?????? ?????????? ??????
?? ???? (0,97+0,049 ?????/?), ??? ? ?????????
? ?????????? ?????? ???? (1,10+0,065), ?? ???
??????? ?? ???? ?????????? ???????? (?=0,06),
?????? ????? ??????? ??????? ?? ???? ?
?????? 1 ????????? ?? 14,7% (?=0,01) ? ??????-
??? ? ??????? 2 - ?? 10,1% (?=0,01) ? ???????
?????????? ????? ???????? ????? ??????????
???????? (?=0,025). ????? ? ?????? 2 ?????????
??/???? ???? ?????????? ????, ??? ? ??????-
??? ? ?????? 1 (?=0,011).
??? ????????, ??????? ???????? ?????
???????????? ????????, ? ??? ????? ?????? ??
??????? ??????????, ???????, ? ???? ???????,
???????? ??????????????? ???????? ????????
????? ????????????? ???. ???????? ???????-
?????? ?? ??????? ??? ?????????????????? ?
??????????? ? ?????? ???????????? ? ??????-
??? ? ???????? ???????? 2 ???? ? ????? ????-
?????? ??????????. ? ??????? 6 ??????? ????-
??? ? ?????? ?????? ????????? ????????
??????????? ???????? ?????? ??? ? ?????????
0,49 ??/? ?? 0,37 ??/?, (?<0,001) [10]. 
?? ???? ?????????? ??????? ????? 8 ??????
??????? ??????? ??? ???????? ?? 28,1% 
(?=0,002), ??? ??????????????? ? ????????????-
????????? ??????? ?????????????. ?? ???????
??????? ??? ? ?????? 1 ????????? 3,15+0,37, ?
?????? 2 - 2,59+2,85 ??/?, ????????????? ? ??????
????????? ? ?????????? ?????? ???? ???????
??????? ??? ?????????? ???????? ?? ??????
2,21+0,45 ?/? (29,8% ) (?=0,007), ? ? ?????? ??????-
??? ? ????????? 1 ??????? – ?? 2,28+1,59 ??/?
(11,9%) (?=0,12) (???. 7). 
????? ???????, ???????? ?????????????,
???????????? ? ????????????? ????????, ???-
????? ? ????????? ? ?????????? ????????-
??????? ???????, ???????? ???????? ??????????.
? ?????? ???????????? ????????? ???? ????-
?????? ??????? ???? ?????????, ????? ???????
????????????? ????????? ?????? ? ?????
???????? ????????. ???????????? ?????????
?????? ?????????? ???????????, ??????????,
????????, ?????????? ???????? ?? ????.
??????? ???????? ????? ??????????
????????????? ???????? ???? ???????????
???????? ????????
??????? ???????????110
????????? ??????? ? ????????? ? ??????????
?????? ???? (??? 25 – 30 ??/?2) ?? ???? ???????
?????????????? ? ???? 2 ?? ? ??????? 8 ??????, ?
??????? ?? ????????? ? ????????? 1 ???????
(??? 30-35 ??/?2), ???, ????????, ???????
??????????? ???????????? ? ????? ?????? ??-










??? ??????  n=20* ?????? 1 n=9* ?????? 2 n=8
*
????????????? ????? ???????????? ?? ???????? ?????????? ?<0,05 
???. 7. ???????? ????????? ??????????? ??? ?? ???? ???????
??????
1. ? ???? ????????? ? ??? ? ????????? ?
????? ???????? ????????????, ????????????
??????? ???????? ????????? ?????? ?? ? 80%, 
?? ???? ? 95%, ???????? ?? ???? ? 40 % 
???????.
2. ? ???????? ????????? ??? ? ??? ? ????-
????? ? ????? ?? ???????? ?????????? ????-
?????? ????? ???? ? ????????? ??? 25-35 ??/?2
? ??????????? ????????? ??????????? ?????-
???? ???????. ? ????????? ? ??? 25 – 30 ??/?2
?? ???? ??????? ?????????????? ? ????  2 ??
???????????????? ????? ??????????? ????????
?? (56,6%), ?? ???? (31,8%), ??? (22%), ???
(29,8%) ? ????????? ?????? ?? ???? (14,7%) 
? ??????? ?? ????????? ? ??? 30-35 ??/?2 - 33,7%, 
22,8%, 8,8%, 10,1%, 11,9% ??????????????.
3. ???????????? ? ???? 2 ?? ? ??????? 8 ??????
? ????????? ? ??? ? ????????? ? ????? ??
??????? ????????? ????????? ?????????? ????-
?????? ???????????, ??????????, ??????????
????????? ???? ??? ?????? ?????????.
?????? ??????????
1. ???? ?.?. ???????????? – ????? ?????????
???-???-?????????: ??????????? ??????????? ???-
????????? ? ??????????? ?????????? ??? ???????
????????-?????????? ??????????? / ?.?. ????,
?.?. ??????, ?.?. ???????? // ??????? ???????????.
– 2013. – ? 4. – ?. 36–44. 
2. ?????? ?.?. ??????? ??????? ??? ????????-
???? ?? ???????? ?????? ?????, ??????? ??????????
?????????? ? ???????? ????????? ????????????
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??????? // ???? ???????.– 2013. – ?9. –  ?. 76-79. 
3. ?????? ?.?. ???????? ????? ? ???????????-
?????? ????? ? ?????? ?? ???????? ??????? ?????:
?????????? / ?.?. ??????, ?.?. ???????. – ??????-
?????????: ?????, 2013. – 112 ?.
4. ??????? ?.?. ?????????????? ?????? ????-
??????? ?????? / ?.?. ???????. – ?.: ??????????,
2006. – 305?.
5. ???????? ?.?. ???????-????????????? ?????-
????????? ?????????????? ?????????????? ? ?????????
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6. A Large-Scale Survey on Cardio-Cerebrovascular 
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